THROMBOTROY QPS SOLUTIONcontains Heparin which belongs to the group of medicines called Anticoagulants. It is used to treat blood clots in leg veins (deep vein thrombosis), blood clots in the lung (pulmonary embolism), chest pains resulting from disease of the heart arteries (unstable angina pectoris), severe blockages affecting arteries in the legs (acute peripheral arterial occlusion).
THROMBOTROY QPS SOLUTION is also used during heart, lung operations, during kidney dialysis and prevention of blood clots in the heart following a heart attack (mural thrombosis). A blood clot or thrombus is a gel-like collection of blood that form in arteries or veins when blood changes from liquid to partially solid form.
THROMBOTROY QPS SOLUTION is not recommended for use if you have liver disease, serious bleeding problems, haemophilia, bruise easily, high blood pressure, tuberculosis, major trauma, have had severe skin problems resulting from previous heparin treatment, surgery of the brain, spine or eye, a lumbar puncture or receiving anesthetic, had an operation, thrombocytopenia, bleeding into the brain, drink a lot of alcohol.
Before receiving THROMBOTROY QPS SOLUTIONinform your doctor if you have kidney disease, diabetes, a condition that makes you bleed easily, or suffer from excess acid or high levels of potassium in your blood. Do not consume alcohol, tobacco, or smoke during this treatment.
THROMBOTROY QPS SOLUTION should be used with caution in pregnant and breastfeeding women. THROMBOTROY QPS SOLUTION is not recommended for use in premature and newborn babies (up to 4 weeks old). Ask for your doctor’s advice.
THROMBOTROY QPS SOLUTION should be used with caution in elderly patients above 60 years of age. The most common side effects of receiving THROMBOTROY QPS SOLUTION are red lumps or red, itchy patches like eczema at injection site. Consult your doctor if symptoms do not show improvement.
To treat,
THROMBOTROY QPS SOLUTION binds to the antithrombin (an enzyme present in the clotting system) which in turn inhibits several clotting factors such as factor Xa, factor IIa. This inactivation of thrombin prevents the formation of clots and prolongs the clotting time of blood.
THROMBOTROY QPS SOLUTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. It should not be given into a muscle. Your doctor will decide the right dose and duration depending on your age, body weight and disease condition.
Stop receiving THROMBOTROY QPS SOLUTION and contact your doctor immediately if you experience any of the following side effects:
Itchy skin:
Hot water makes your skin irritated, so avoid taking hot showers. Do not scratch the affected area. Use sunscreen and protective clothing when outdoors. To soothe and hydrate irritated skin, apply moisturizers. Contact your doctor if the itching worsens.
THROMBOTROY QPS SOLUTION should be used with caution in pregnant women. Inform your doctor or nurse know prior to receiving THROMBOTROY QPS SOLUTION if you are pregnant, wish to become pregnant or have a history of, or have a known risk of miscarriage. If THROMBOTROY QPS SOLUTION is given, bleeding may be a problem during pregnancy or after delivery. Your bones may get thinner if you receive THROMBOTROY QPS SOLUTION for a long-time during pregnancy. If you are pregnant and are going to have an epidural anesthetic, you should stop having the medicine. Consult your doctor before receiving it.
THROMBOTROY QPS SOLUTION should be used with caution in breastfeeding women as it will be given to you after evaluating the risk and benefit ratio. Consult your doctor before receiving it.
THROMBOTROY QPS SOLUTION does not affect your ability to drive or use machines.
Do not consume alcohol while receiving THROMBOTROY QPS SOLUTION.
THROMBOTROY QPS SOLUTION should be used with caution patients having kidney disease, dose will be adjusted by your doctor. Consult your doctor before receiving
THROMBOTROY QPS SOLUTIONis not recommended for use in patients who suffer from severe liver problems which can lead to bleeding into the esophagus. THROMBOTROY QPS SOLUTION should be used with caution in mild to moderate liver disease, dose will be adjusted by your doctor. Consult with your doctor before receiving THROMBOTROY QPS SOLUTION.
Do not receive THROMBOTROY QPS SOLUTION if you are allergic to Heparin or any other ingredients of this medicine.
THROMBOTROY QPS SOLUTION is not recommended for use if you:
Before receiving THROMBOTROY QPS SOLUTION, inform your doctor if you:
Use in pediatrics:
THROMBOTROY QPS SOLUTION is not recommended for use in premature and newborn babies (up to 4 weeks old). Consult with your child’s doctor.
Use in geriatrics:
THROMBOTROY QPS SOLUTIONshould be used with caution in elderly patients above 60 years of age. Dose will be adjusted by your doctor. Consult your doctor before receiving it.
A. Drug - Drug interactions:
Before receiving THROMBOTROY QPS SOLUTION, inform your doctor if you are taking any of the following medicine:
Overdosage:
THROMBOTROY QPS SOLUTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms like severe bleeding.
Drug | : | Heparin |
Pharmacological Category | : | Anticoagulant |
Therapeutic Indication | : | Blood clots |
Dosage Forms | : | Gel, Injection, Solution, Topical solution |
Can THROMBOTROY QPS SOLUTION be received by children?
THROMBOTROY QPS SOLUTION is not recommended for use in premature and newborn babies (up to 4 weeks old). Dose will be adjusted by your doctor depending on your age, body weight and disease condition. Consult your doctor before receiving
Can THROMBOTROY QPS SOLUTION be received by pregnant women?
THROMBOTROY QPS SOLUTION should be used with caution in pregnant women. Inform your doctor or nurse know prior to receiving THROMBOTROY QPS SOLUTION if you are pregnant, wish to become pregnant or have a history of, or known risk to miscarriage. If THROMBOTROY QPS SOLUTION is given, bleeding may be a problem during pregnancy or after delivery. Your bones may get thinner if you receive THROMBOTROY QPS SOLUTION for a long-time during pregnancy. If you are pregnant and are going to have an epidural anesthetic, you should stop having the medicine. Consult your doctor before receiving it.
Can I smoke while receiving THROMBOTROY QPS SOLUTION?
Avoid smoking while receiving THROMBOTROY QPS SOLUTION. Tobacco smoke can also interfere with the working of THROMBOTROY QPS SOLUTION. Ask for your doctor’s advice and inform your doctor if you smoke.
Can I Keep receiving THROMBOTROY QPS SOLUTION if I have a planned surgery?
You must remind your doctor that you are having THROMBOTROY QPS SOLUTION before you receive any anesthetic. After you have the anesthetic your doctor or nurse might make regular checks to make sure you are not getting any major bleeding or bruising around your spine which may cause paralysis that could be permanent. After you have the anesthetic, your doctor will tell you when you can take THROMBOTROY QPS SOLUTION again.
Do I need to undergo any diagnostic tests while receiving THROMBOTROY QPS SOLUTION?
The presence of THROMBOTROY QPS SOLUTION in the blood can affect the results of some blood tests such as thyroid tests and the levels of calcium or some antibiotics such as gentamicin in the blood. Your doctor might ask you to take several diagnostic tests.
Will I be given a test dose of THROMBOTROY QPS SOLUTION?
If you suffer from allergies or have previously had an allergic reaction to heparin, a small test dose of THROMBOTROY QPS SOLUTION may be given first to make sure that you are not allergic to it.
1. KD Tripathi. Drugs Affecting Coagulation, Bleeding and Thrombosis. Essentials of medical pharmacology. Eighth Edition. 2019. Page –663-664
2. Mandana Izadpanah, Hossein Khalili, Mostafa Mohammadi. Comparing safety of heparin as continuous intravenous infusion and multiple subcutaneous injections. NIH National Library of Medicine, National Centre for Biotechnology Information. Pubmed.gov. December 2015. [Accessed on 10th August 2022] https://pubmed.ncbi.nlm.nih.gov/26689885/
3. Eziafa, Oduah, Robert J. Linhardt, and Susan T. Sharfstein. Heparin: Past, Present, and Future. NIH National Library of Medicine, National Centre for Biotechnology Information. Pubmed Central. September 2016. [Accessed on 10th August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039491/
4. CP Pharmaceuticals Ltd. Electronic Medicines Compendium (EMC). [Revised in June 2018] [Accessed on 10th August 2022] https://www.medicines.org.uk/emc/files/pil.1678.pdf
5. CP Pharmaceuticals Ltd. Electronic Medicines Compendium (EMC). [Revised in June 2018] [Accessed on 10th August 2022] https://www.medicines.org.uk/emc/files/pil.1680.pdf
6. Fresenius Kabi. U.S. Food & Drug Administration. [Revised in August 2017] [Accessed on 10th August 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017029s140lbl.pdf
7. Pfizer Laboratories Div Pfizer Inc. Heparin Sodium. Dailymed. [Revised in May 2020]. [Accessed on 10th August 2022] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56dc3074-f1c5-45a3-b923-f1d14858e06d
8. Troikaa Pharmaceuticals. Cathflush (Heparin Sodium). [Accessed on 10th August 2022] https://www.troikaa.com/wp-content/uploads/2021/10/Common-Products-List-Novogen-Excluded.pdf
9. Drug bank. Heparin. [Accessed on 10th August 2022] https://go.drugbank.com/drugs/DB01109
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.